USPH

U S Physical Therapy Inc /nv Health Care Services-Health Services Russell 3000
$85.83Close $1.5BMarket cap $58.22 – $88.7352-week range Nov 4, 2026Next report · after the close

Highlights

Strengths

  • Near its high 3% below its 52-week high

Cautions

  • Trend not confirmed 6 of 8 conditions · 150-day under the 200-day, RS under 70
  • Earnings shrinking EPS −19% year on year
  • Results soon Nov 4, 2026, in 3 days

Price

Filing Results Screen pick 52-week high and low Adjusted prices

Key figures

FY to Dec 31, 2025 · filed Aug 7, 2026
Off 12-month high 3%
1wk down 3.0% price change
1mo up 0.1% price change
12-month return up 2% market up 11% · its own down 11%
F-score 6 / 9 Mixed
Altman Z″ 2.26 Moderate risk
P/E 37.8× price / earnings
PEG 1.51 P/E / EPS growth
P/B 3.1× price / book
Earnings yield up 5.4% EBIT / enterprise value
Cheaper than 60% of the market · cheap
Revenue growth up 16% year on year
EPS growth down 19% latest quarter · +30 pts
Sales growth up 8% latest quarter · +1 pts
ROE up 8% return on equity
Free cash margin up 8% $61.0M FCF
D/E 0.32 long-term debt / equity
Net debt / EBITDA 1.1×
Interest cover —EBIT / interest
Piotroski tests
  • short-term liquidity weakened
  • issued more shares
  • assets working less efficiently
  • profitable on its assets
  • generating cash from operations
  • profitability improving
  • profits backed by cash
  • reduced long-term debt
  • gross margin widened

Trade setup

ATR% 3.1% $2.67 a day · 2×ATR $80.48
RS 61 / 99 vs the universe
Trend 6 / 8 150-day under the 200-day, RS under 70
Relative volume 0.9× vs 50-day average
Up/down volume 1.16 50 sessions
Implied move — no option chain · report Nov 4, 2026
Trend template · 6 of 8
  • 150-day average above the 200-day: fails
  • RS rank 70 or higher: fails

Screen verdict

Did not qualify for any screen.

Warning signs

none flagged
  • No restatement or impairment
  • Equity positive
  • Interest covered
  • No material dilution
  • Profits tracking cash
  • Margins and revenue not shrinking
Last reported Aug 6, 2026
Results reaction Aug 6, 2026+3% vs market2 sessions after results

Financials

6 fiscal years · from filings
Revenue What customers paid the company over its fiscal year, before any cost, as filed in its annual report. The change is against the year before. Methodology $781.0M +16% on FY2024
$0 $1B FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $423.0M FY2021 · $495.0M FY2022 · $553.1M FY2023 · $604.8M FY2024 · $671.3M FY2025 · $781.0M
Net income Profit left after every cost, interest and tax for the year. A column below the line is a loss. Methodology $39.6M +26% on FY2024
$0 $50M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $35.2M FY2021 · $40.8M FY2022 · $32.2M FY2023 · $28.2M FY2024 · $31.4M FY2025 · $39.6M
Free cash flow Cash from running the business less what it spent on equipment and buildings: the cash a year actually left behind, which profit alone does not show. Not shown for banks and insurers, whose cash moves with their loans. Methodology $61.0M -7% on FY2024
$0 $100M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · $92.4M FY2021 · $68.2M FY2022 · $50.3M FY2023 · $72.7M FY2024 · $65.8M FY2025 · $61.0M
Margins Each as a share of revenue. Gross: left after the direct cost of what was sold. Net: left after every cost. Free cash: free cash flow over revenue. A margin rising over years means the business keeps more of each dollar it sells. Methodology
  • Gross 19%
  • Net 5%
  • Free cash 8%
0% 25% FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Gross 22% · Net 8% · Free cash 22% FY2021 · Gross 24% · Net 8% · Free cash 14% FY2022 · Gross 20% · Net 6% · Free cash 9% FY2023 · Gross 20% · Net 5% · Free cash 12% FY2024 · Gross 18% · Net 5% · Free cash 10% FY2025 · Gross 19% · Net 5% · Free cash 8%
Cash and long-term debt Cash on the balance sheet at the year's end beside debt due after a year. Net cash is cash less that debt; net debt is the shortfall. Debt some filers do not tag shows as a gap, not as zero. Methodology $117.0M net debt
  • Cash
  • Long-term debt
$0 $200M FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · Cash $32.9M · Long-term debt $16.6M FY2021 · Cash $28.6M · Long-term debt $117.6M FY2022 · Cash $31.6M · Long-term debt $175.8M FY2023 · Cash $152.8M · Long-term debt $139.0M FY2024 · Cash $41.4M · Long-term debt $142.5M FY2025 · Cash $35.6M · Long-term debt $152.6M
Shares outstanding Shares in issue at the year's end. A rising count means each share owns a smaller slice of the company (stock pay, share sales); a falling one, buybacks. The chart's scale is fitted to the count, so a small change looks large: read the percentage. Methodology 17.42m +15.6% since FY2020
17.42m 15.07m FY20 FY21 FY22 FY23 FY24 FY25 FY2020 · 15.07m FY2021 · 15.13m FY2022 · 15.22m FY2023 · 17.20m FY2024 · 17.31m FY2025 · 17.42m
  FY2020Dec 31, 2020 FY2021Dec 31, 2021 FY2022Dec 31, 2022 FY2023Dec 31, 2023 FY2024Dec 31, 2024 FY2025Dec 31, 2025
Revenue $423.0M $495.0M $553.1M $604.8M $671.3M $781.0M
Gross margin 22% 24% 20% 20% 18% 19%
Operating income $52.4M $70.6M $56.8M $50.5M $63.0M $86.7M
Net income $35.2M $40.8M $32.2M $28.2M $31.4M $39.6M
Net margin 8% 8% 6% 5% 5% 5%
Earnings per share $2.74 $3.17 $2.48 $1.99 $2.09 $2.61
Free cash flow $92.4M $68.2M $50.3M $72.7M $65.8M $61.0M
Free cash margin 22% 14% 9% 12% 10% 8%
Cash $32.9M $28.6M $31.6M $152.8M $41.4M $35.6M
Long-term debt $16.6M $117.6M $175.8M $139.0M $142.5M $152.6M
Shareholders' equity $276.2M $295.6M $315.8M $476.2M $488.9M $476.4M
Shares outstanding 15.07m 15.13m 15.22m 17.20m 17.31m 17.42m

Filings

SEC EDGAR
FiledReportPeriod to Lag
Aug 7, 2026 Quarterly ↗ Jun 30, 2026 38d
May 8, 2026 Quarterly ↗ Mar 31, 2026 38d
Feb 27, 2026 Annual ↗ Dec 31, 2025 58d
Nov 7, 2025 Quarterly ↗ Sep 30, 2025 38d
Aug 8, 2025 Quarterly ↗ Jun 30, 2025 39d
May 9, 2025 Quarterly ↗ Mar 31, 2025 39d
Mar 3, 2025 Annual ↗ Dec 31, 2024 62d
Nov 8, 2024 Quarterly ↗ Sep 30, 2024 39d
Aug 14, 2024 Quarterly ↗ Jun 30, 2024 45d
May 8, 2024 Quarterly ↗ Mar 31, 2024 38d
Feb 29, 2024 Annual ↗ Dec 31, 2023 60d
Nov 8, 2023 Quarterly ↗ Sep 30, 2023 39d

Current reports